- €4.82bn
- €6.25bn
- €3.77bn
- 78
- 80
- 74
- 92
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,204 | 2,108 | 2,395 | 4,062 | 3,769 |
Cost of Revenue | |||||
Gross Profit | 803 | 899 | 862 | 1,050 | 1,397 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,800 | 1,835 | 2,008 | 3,731 | 3,241 |
Operating Profit | 404 | 273 | 387 | 332 | 528 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 374 | 257 | 366 | 301 | 656 |
Provision for Income Taxes | |||||
Net Income After Taxes | 327 | 229 | 352 | 237 | 582 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 302 | 200 | 325 | 210 | 530 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 302 | 200 | 325 | 210 | 530 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.59 | 1.27 | 2.35 | 1.69 | 3.11 |
Dividends per Share |